The value of synthetic oestrogen in carcinoma of the prostate is now widely recognised. The pain of bone secondaries in such patients is usually materially reduced, and it is generally accepted that in most cases there is prolongation of life with freedom from severe pain.
The possibilities of these drugs in late inoperable carcinoma of the breast are much less widely known. Generally surgeons and radiotherapists feel that the patient is in a hopeless and helpless position and must rely on sedation. It has been shown, however, that a small but fairly constant proportion of these women can have relief of pain and prolongation of life with oestrogen therapy, similar to that obtained in prostatic neoplasm.
This infrequent use of oestrogen may in part be due to the publication, from time to time, of papers suggesting that these hormones have carcinogenic properties.* In 1932 I,acassagne showed that oestrone could cause mammary carcinoma with great regularity in male mice of cancerprone stock.
Recently Moore et al. (1945) showed that during the administration of oestrogen for carcinoma of the prostate there is a proliferation of the mammary duct epithelium similar to that preceding malignancy. There does not, however, seem to be any case on record where the development of a malignant growth in the human could be ascribed to oestrogen therapy. May, 1947 , with scirrhous carcinoma of the whole left breast extending subcutaneously to involve the medial half of the right breast. Duration about 5 years, and had had repeated courses of X-ray therapy.
There was superficial ulceration over an area 3|" X 3" on left breast. Stilboestrol rapidly caused anorexia and nausea and was replaced by dienoestrol, 9 mgni. per daj-. This caused no side-effects ; the ulcerated area became cleaner and was reduced to 3" x 2" by 9th June, but a pulmonary metastasis with effusion had appeared. The latter was uninfluenced by the drug and caused death from broncho-pneumonia on 27th August, with the breast condition still apparently improving. 
